LeMaitre Vascular Inc (LMAT)
94.90
+2.15
(+2.32%)
USD |
NASDAQ |
Jan 08, 16:00
99.99
+5.09
(+5.36%)
After-Hours: 04:52
LeMaitre Vascular SG&A Expense (Quarterly): 20.37M for Sept. 30, 2024
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Globus Medical Inc | 240.74M |
| Insulet Corp | 234.10M |
| Baxter International Inc | 754.00M |
| Boston Scientific Corp | 1.562B |
| ResMed Inc | 238.98M |